retatrutide mechanism of action triple agonist glp-1 gip glucagon ly3437943 Beyond GLP-1: Retatrutide's triple-agonist (GLP-1, GIP, glucagon) is redefining Dual and Triple Gut Peptide

Suppresses appetite, some patients may experience mild nausea (with or without vomiting) and abdominal pain that improves with use

A 2025 human pilot study reported no adverse cardiac, hepatic, or renal effects at IV doses of 10-20mg

How to take it: Take Contrave by mouth with a meal

Under conditions of metabolic stress (such as exercise or fasting), our mitochondria naturally increase MOTS-c production

Heavy agency use can create a costly cycle of higher fees, weaker alignment, increased turnover, and lost productivity

Ideal for those looking to reduce dark spots, even out skin tone, and protect their skin from environmental stressors